Indo Borax to Acquire 64.26% in Kronox Lab Sciences via Open Offer

BANKINGFINANCE
Whalesbook Corporate News Logo
AuthorRiya Kapoor|Published at:
Indo Borax to Acquire 64.26% in Kronox Lab Sciences via Open Offer

Indo Borax and Chemicals is launching an open offer to acquire up to 25.79% of Kronox Lab Sciences at Rs 157.27 per share. This follows a deal to buy a 64.26% stake, changing ownership and management.

Indo Borax Launches Open Offer for Kronox Lab Sciences

Indo Borax and Chemicals Limited is launching a mandatory open offer for Kronox Lab Sciences Ltd. shares, aiming to acquire up to 95,70,000 equity shares, representing 25.79% of the voting share capital.

Reader Takeaway: Ownership change with higher open offer price signals potential value for existing shareholders, but deal conditions apply.

What just happened

Indo Borax and Chemicals Limited (the Acquirer) has triggered a mandatory open offer for Kronox Lab Sciences Ltd. This is a consequence of an executed Share Purchase Agreement (SPA) where the Acquirer agreed to buy 64.26% of Kronox Lab Sciences from its existing promoters.

Why this matters

This transaction signifies a complete change in ownership and control of Kronox Lab Sciences. The Acquirer will become the new promoter, and the existing promoters will exit. The open offer price is higher than the SPA price, which could be beneficial for minority shareholders.

The backstory

On August 20, 2026, the Acquirer and a PAC entered into an SPA with sellers Ketan Vinodchandra Ramani, Pritesh Vinodchandra Ramani, and Jogindersingh Gianchand Jaswal. They agreed to purchase 2,38,44,000 equity shares, or 64.26% of Kronox Lab Sciences, for Rs 246.12 crore.

An important detail is the consultancy agreement with the sellers for 36 months post-closing, with an aggregate fee of Rs 6.30 crore. This consultancy fee increases the effective SPA price per share to Rs 105.87 for regulatory purposes.

What changes now

Upon completion of the SPA and the open offer, Indo Borax and Chemicals will become the promoter of Kronox Lab Sciences. The current sellers will cease to be in control and will be reclassified as public shareholders.

Risks to watch

The transaction is subject to the conditions precedent outlined in the SPA. Shareholders should await the Detailed Public Statement, expected by August 28, 2026, for full details.

Context metrics (time-bound)

  • SPA Price: Rs 103.22 per share.
  • Effective SPA Price (incl. consultancy): Rs 105.87 per share.
  • Open Offer Price: Rs 157.27 per share.
  • Open Offer Size: Up to 95,70,000 shares (25.79% of voting capital).
  • Total Open Offer Consideration: Rs 150.51 crore.
  • Detailed Public Statement Due: On or before August 28, 2026.

What to track next

Investors should closely monitor the publication of the Detailed Public Statement. They should also assess the conditions precedent for the SPA's completion and the outcome of the open offer.

Disclaimer: This article is published for informational purposes only. This is not a buy sell recommendation.